Two executives at Roivant Sciences Ltd. (ROIV) sold shares totaling approximately $11.55 million on November 12, 2026. Eric Venker, President & Immunovant CEO, sold 158,194 shares at an average price of $40.44 per share, amounting to $6.40 million. Concurrently, Richard Pulik, the Chief Financial Officer, sold 125,000 shares at an average price of $41.20 per share, totaling $5.15 million.
These transactions occurred as part of a series of sales by both executives in early November. While insider selling can be attributed to various personal financial strategies such as diversification or tax planning, significant or clustered sales by multiple insiders may draw investor attention.
The reported sales add to recent insider activity at Roivant Sciences. Richard Pulik had previously sold shares on November 11, 2026, in multiple transactions totaling over $7.3 million. Eric Venker also engaged in a sale on November 10, 2026, for approximately $1.22 million.